amount of it in DMSO. Stock solutions of other substances were prepared by dissolving in PBS or water.
Apparatus. Fluorescence measurements were made on a Hitachi F-4600 fluorimeter (Tokyo, Japan). UV-vis absorption spectra were measured in 11 cm quartz cells with a TU-1900 spectrophotometer (Beijing, China) . A model HI-98128 pH-meter (Hanna Instruments Inc., USA) was used for pH measurements. instrument. High resolution electrospray ionization mass spectra (HR-ESI-MS) were recorded on an APEX IV FTMS instrument (Bruker, Daltonics). Cell imaging experiments were operated on a FV 1000-IX81 confocal laser scanning microscope (Olympus, Japan). The fluorescence quantum yield (Φ) was determined by using fluorescein (Φ = 0.85 in 0.1 M NaOH) as a standard (Zhang et al, J. Am. Chem. Soc. 2011, 133, 14109) . The western blot signal was detected using an ECL kit. Image processing was made with Olympus ImageJ software (National Institutes of Health, USA). Cytotoxicity assay was made on microtiter plate assay system (Molecular Devices, USA).
Synthesis of probe 1. N-(tert-Butoxycarbonyl)-L-pyroglutamic acid (229 mg, 1.0 mmol), HATU (570 mg, 1.5 mmol) and DIPEA (2.0 mmol, 435 L) were added to 30 mL of acetonitrile at 0 °C. After stirring for 40 min, cresyl violet acetate (321 mg 1.0 mmol) was added slowly, and the reaction mixture was further stirred at room temperature for 3 h. Then, the mixture was diluted with ethyl acetate, and washed three times with water (100 mL×3).
The solvent was removed by evaporation under reduced pressure, and the crude product was purified by silica gel chromatography eluted with CH 2 Cl 2 /methanol (v/v, 20/1) .6, 172.4, 150.7, 133.4, 132.6, 130.5, 126.2, 125.2, 84.6, 71.0, 61.9, 36.3, 32.8, 31.9, 30.5, 30.3, 30.1, 30.0, 27.9, 26.6, 23.4, 22.6, 14. 172.7, 158.5, 158.3, 145.0, 142.3, 131.9, 131.0, 125.2, 124.9, 118.9, 116.9, 105.8, 72.8, 60.8, 56.9, 29.7, 29.5, 25.8, 21.7, 14.5 General procedure for PGP-1 detection. Unless otherwise stated, all the fluorescence measurements were made according to the following procedure. In a test tube, 5 μL of stock solution of probe 1 and appropriate volume of PBS were mixed, followed by addition of an appropriate volume of PGP-1 or other substance solutions. The mixed solution was adjusted to 1 mL with PBS. After incubation at 37 °C for 30 min, the reaction solution was transferred to a quartz cell of 1-cm optical length to measure fluorescence with  ex/em = 585/625 nm (both excitation and emission slit widths were set to 5 nm). For absorbance measurements, 2 mL of reaction solution was prepared and used. At the same time, a blank solution without PGP-1 was prepared and measured under the same conditions for comparison. Data are expressed as mean  standard deviation (SD) of three separate measurements. Cytotoxicity assay. The cytotoxicity of probe 1 was tested on LO-2 cells using a standard MTT assay, as described previously (Gong et al, Chem. Sci. 2016, 7, 788) .
Preparation of cell lysates. The cell lysates were prepared according to our previous method (Gong et al, Chem. Sci. 2016, 7, 788) .
Western blot. Unless otherwise stated, all the western blot analyses were made by using GAPDH (glyceraldehyde-3-phosphate dehydrogenase) as a protein standard. In brief, cells (LO-2 or RAW264.7, including control group, and FIA, LPS and inhibitor treated groups)
were lysed with RIPA buffer, and the cell lysates were diluted 10 times with PBS to obtain a solution of about 0.5 mg/mL of total proteins. The diluted cell lysates were incubated with Anti-PGP-1 or Anti-TNF- antibody for 3 h at room temperature, and then incubated with Protein A/G Agarose for 1.5 h at room temperature. The agarose beads were pelleted by centrifugation at 4 °C (14000 rpm for 5 min), and the PGP-1 or TNF--depleted supernatant was collected and preserved at -70 °C. For western blot analysis, equal amounts of protein in cell lysates were separated by SDS-PAGE and electroblotted onto PVDF membranes. After blocking with 5% skim milk in TBST (20 mM Tris, pH 7.6, 140 mM NaCl, and 0.1% Tween-20) at room temperature for 1.5 h, the membranes were incubated with the corresponding primary antibodies at 4 °C overnight. The membranes were washed with TBST for three times and further incubated with the horseradish peroxidase-conjugated secondary antibodies at room temperature for 2 h. Finally, the signal was detected using an ECL kit. The grayscale value was analyzed by Gel-Pro32 software.
Immunofluorescence assay. The immunofluorescence images were recorded according to the previous methods (Zhu et al, Nat. Commun. 2016, 7, 10080; Ensink et al, Anal. Chem. 2015, 87, 9715) in KeyGEN BioTECH Co. Ltd, Nanjing, China.
Statistical tests. The t analysis was operated according to our previous method (Gong et al, Chem. Sci. 2016, 7, 788) . The effects of iodoacetamide at varied concentrations on the fluorescence intensity of (1) probe 1 (5 μM) and (2) cresyl violet (5 μM). The reactions were performed at 37 °C for 30 min in 6.7 mM PBS (pH 7.4). λ ex/em = 585/625 nm. As is seen, the presence of iodoacetamide does not affect the fluorescence of probe 1 and its reaction product. (2) its reaction with PGP-1 (2 μg/mL). All the reactions were performed in 6.7 mM PBS (pH 7.4) at 37 °C for 30 min. λ ex/em = 585/625 nm. 
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